Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Transplantation and Cellular Therapy
|
July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
Qaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Clopidogrel Pharmacogenetics
Naveen L Pereira, Charanjit S Rihal, Derek Y F So, et al.
JMIR Formative Research
|
June 14, 2022
Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study
Robert Avram, Derek So, Erin Iturriaga, et al.
Heart (British Cardiac Society)
|
May 28, 2026
COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype
Archit Singhal, Ellen Appleby, Owen Agnel, et al.
American Journal of Hematology
|
May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma
Anita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Circulation
|
March 10, 2004
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Scott D Corley, Andrew E Epstein, John P DiMarco, et al.
Blood Cancer Journal
|
February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
Blood Advances
|
August 21, 2024
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
Betty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival
Marcelo C Pasquini, Paul K Wallace, Brent Logan, et al.
JACC. Cardiovascular Interventions
|
April 12, 2023
Genetic-Guided Oral P2Y<sub>12</sub> Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention
Brenden S Ingraham, Michael E Farkouh, Ryan J Lennon, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Transplantation and Cellular Therapy
|
July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
Qaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Clopidogrel Pharmacogenetics
Naveen L Pereira, Charanjit S Rihal, Derek Y F So, et al.
JMIR Formative Research
|
June 14, 2022
Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study
Robert Avram, Derek So, Erin Iturriaga, et al.
Heart (British Cardiac Society)
|
May 28, 2026
COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype
Archit Singhal, Ellen Appleby, Owen Agnel, et al.
American Journal of Hematology
|
May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma
Anita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Circulation
|
March 10, 2004
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Scott D Corley, Andrew E Epstein, John P DiMarco, et al.
Blood Cancer Journal
|
February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
Blood Advances
|
August 21, 2024
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
Betty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival
Marcelo C Pasquini, Paul K Wallace, Brent Logan, et al.
JACC. Cardiovascular Interventions
|
April 12, 2023
Genetic-Guided Oral P2Y<sub>12</sub> Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention
Brenden S Ingraham, Michael E Farkouh, Ryan J Lennon, et al.
Page
of 6